BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14632770)

  • 1. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
    Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
    Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
    Zwaan CM; Kaspers GJ; Pieters R; Ramakers-Van Woerden NL; den Boer ML; Wünsche R; Rottier MM; Hählen K; van Wering ER; Janka-Schaub GE; Creutzig U; Veerman AJ
    Blood; 2000 Oct; 96(8):2879-86. PubMed ID: 11023525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia.
    Yamada S; Hongo T; Okada S; Watanabe C; Fujii Y; Ohzeki T
    Leukemia; 2001 Dec; 15(12):1892-7. PubMed ID: 11753610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity.
    Dübbers A; Würthwein G; Müller HJ; Schulze-Westhoff P; Winkelhorst M; Kurzknabe E; Lanvers C; Pieters R; Kaspers GJ; Creutzig U; Ritter J; Boos J
    Br J Haematol; 2000 May; 109(2):427-9. PubMed ID: 10848836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
    Shman TV; Belevtsev MV; Buglova SE
    Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.
    Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ
    J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukaemia niche regulates response to L-asparaginase.
    Michelozzi IM; Granata V; De Ponti G; Alberti G; Tomasoni C; Antolini L; Gambacorti-Passerini C; Gentner B; Dazzi F; Biondi A; Coliva T; Rizzari C; Pievani A; Serafini M
    Br J Haematol; 2019 Aug; 186(3):420-430. PubMed ID: 31044436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
    Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.
    Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M
    J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
    Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.
    Stam RW; Hubeek I; den Boer ML; Buijs-Gladdines JG; Creutzig U; Kaspers GJ; Pieters R
    Leukemia; 2006 Jan; 20(1):179-82. PubMed ID: 16307022
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute leukemia. Case material and therapeutic results].
    Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
    Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia.
    Rots MG; Pieters R; Jansen G; Kaspers GJ; Van Zantwijk CH; Noordhuis P; Voorn DA; Van Wering ER; Creutzig U; Veerman AJ; Peters GJ
    Eur J Cancer; 2001 Mar; 37(4):492-8. PubMed ID: 11267859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia.
    Yang L; Cao L; Yang M; Tang D; Kang R; Min X; Zhu S; Yu Y
    Oncol Rep; 2013 Apr; 29(4):1459-66. PubMed ID: 23404246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets.
    Goemans BF; Zwaan CM; Harlow A; Loonen AH; Gibson BE; Hählen K; Reinhardt D; Creutzig U; Heinrich MC; Kaspers GJ
    Blood; 2005 Nov; 106(10):3532-7. PubMed ID: 16051737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA; Rubinstein L; Ungerleider RS
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Liu F; Wan Y; Chang L; Guo Y; Yang W; Wang S; Chen X; Liu T; Ruan M; Zhang L; Liu X; Zou Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):215-7. PubMed ID: 24824393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.